These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2177401

  • 1. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    Barnett G, Segura J, de la Torre R, Carbó M.
    Eur J Clin Pharmacol; 1990; 39(1):63-9. PubMed ID: 2177401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.
    Harder S, Fuhr U, Staib AH, Wolff T.
    Am J Med; 1989 Nov 30; 87(5A):89S-91S. PubMed ID: 2589393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT.
    Scand J Infect Dis Suppl; 1986 Nov 30; 49():115-23. PubMed ID: 3547618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans.
    Sano M, Kawakatsu K, Ohkita C, Yamamoto I, Takeyama M, Yamashina H, Goto M.
    Eur J Clin Pharmacol; 1988 Nov 30; 35(2):161-5. PubMed ID: 3191935
    [Abstract] [Full Text] [Related]

  • 8. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA, Depta JP, Pichler WJ.
    Clin Exp Allergy; 2006 Jan 30; 36(1):59-69. PubMed ID: 16393267
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA.
    Am J Med; 1992 Apr 06; 92(4A):22S-25S. PubMed ID: 1580270
    [Abstract] [Full Text] [Related]

  • 13. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
    Sarkar M, Polk RE, Guzelian PS, Hunt C, Karnes HT.
    Antimicrob Agents Chemother; 1990 Apr 06; 34(4):594-9. PubMed ID: 2344166
    [Abstract] [Full Text] [Related]

  • 14. Overview of the fluoroquinolone antibiotics.
    Just PM.
    Pharmacotherapy; 1993 Apr 06; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [Abstract] [Full Text] [Related]

  • 15. Interaction between quinolones and caffeine.
    Staib AH, Stille W, Dietlein G, Shah PM, Harder S, Mieke S, Beer C.
    Drugs; 1987 Apr 06; 34 Suppl 1():170-4. PubMed ID: 3481318
    [Abstract] [Full Text] [Related]

  • 16. The bactericidal effect on Pseudomonas strains of adriamycin associated with quinolones.
    Castelli M, Baggio G, Aresca P, Bossa R, Galatulas I.
    Anticancer Res; 1989 Apr 06; 9(3):611-4. PubMed ID: 2504105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.
    Fuhr U, Anders EM, Mahr G, Sörgel F, Staib AH.
    Antimicrob Agents Chemother; 1992 May 06; 36(5):942-8. PubMed ID: 1510417
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Gyrase inhibitors modify metabolising processes in the liver].
    Staib AH, Harder S, Papenburg A, Stille W.
    Dtsch Med Wochenschr; 1987 Oct 30; 112(44):1720-1. PubMed ID: 2822371
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.